Efficacy and safety of nibentan for cardioversion in patients with persistent atrial fibrillation with and without amiodarone therapy

被引：0
|
作者：
Berkowitsch, A.
Rivin, A.
Medvedev, M.
Zaltsberg, S.
Shubik, I.
机构：
[1] Kerckhoff Klin, Bad Nauheim, Germany
[2] NW Ctr Diagnost & Treatmen, St Petersburg, Russia
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：888 / 888
页数：1
相关论文
共 50 条
  • [1] The efficacy and safety of new class III antiarrhythmic drug nibentan for cardioversion in patients with persistent atrial fibrillation
    Bregvadze, I. N.
    Maykov, E. B.
    Sokolov, S. F.
    Golitsyn, S. P.
    Rozenshtraukh, L. V.
    Chazov, E. I.
    EUROPEAN HEART JOURNAL, 2006, 27 : 887 - 887
  • [2] Nibentan - A drug for pharmacological cardioversion of persistent atrial fibrillation
    Shubik, YV
    Medvedev, MM
    Rivin, AE
    KARDIOLOGIYA, 2005, 45 (03) : 19 - 23
  • [3] The predictors of the efficacy of pharmacological cardioversion with class III antiarrhythmic drug - nibentan in patients with persistent atrial fibrillation
    Bregvadze, I.
    Maykov, E.
    Sokolov, S.
    Golitsyn, S.
    Rozenshtraukh, L.
    Chazov, E.
    Pagava, Z.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1374 - 1374
  • [4] The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration
    Bregvadze, I. N.
    Maykov, E. B.
    Bildinov, O. A.
    Kratskina, T. L.
    Klimenko, Yu. L.
    Smirnova, M. Yu.
    Sokolov, S. F.
    Golitsyn, S. P.
    Rozenshtraukh, L. V.
    Chazov, E. I.
    KARDIOLOGIYA, 2007, 47 (03) : 48 - 55
  • [5] Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone
    Fragakis, N
    Papadopoulos, N
    Papanastasiou, S
    Kozirakis, M
    Maligkos, G
    Tsaritsaniotis, E
    Katsaris, G
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (09): : 954 - 961
  • [6] Ibutilide improves cardioversion success rates in patients on chronic amiodarone therapy with persistent atrial fibrillation
    Hu, JC
    Machuca, K
    DePeralta, S
    Singh, B
    Feliciano, Z
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 136A - 136A
  • [7] Efficacy and Safety of Bepridil for Patients with Persistent Atrial Fibrillation after Failed Electrical Cardioversion
    Egami, Yasuyuki
    Nishino, Masami
    Taniike, Masayuki
    Makino, Nobuhiko
    Kato, Hiroyasu
    Shutta, Ryu
    Tanouchi, Jun
    Yamada, Yoshio
    JOURNAL OF ARRHYTHMIA, 2011, 27 (02) : 131 - 136
  • [8] Efficacy of amiodarone for preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation after cardioversion
    Komatsu, Takashi
    Tachibana, Hideaki
    Sato, Yoshihiro
    Ozawa, Mahito
    Nakamura, Motoyuki
    Okumura, Ken
    CIRCULATION JOURNAL, 2007, 71 (01) : 46 - 51
  • [9] Internal low energy atrial cardioversion: Efficacy and safety in older patients with chronic persistent atrial fibrillation
    Boriani, G
    Biffi, M
    Magagnoli, G
    Zannoli, R
    Branzi, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (01) : 80 - 84
  • [10] Chemical cardioversion of atrial fibrillation with intravenous amiodarone in patients receiving amiodarone therapy: is it reasonable?
    Vardas, P
    Kochiadakis, GE
    Manios, EG
    Igoumenidis, NE
    Kanoupakis, EM
    Skalidis, EI
    EUROPEAN HEART JOURNAL, 2001, 22 : 19 - 19
12345